Are you Dr. Brunhoeber?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
100 Midland Ave
Port Chester, NY 10573Phone+1 800-942-3376Fax+1 914-934-9819
Summary
- Dr. Patrick Brunhoeber, MD is a board certified pathologist in Port Chester, New York. He is currently licensed to practice medicine in New York, Connecticut, and Arizona.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Molecular Genetic Pathology, 2009 - 2010
- SUNY Downstate Health Sciences UniversityFellowship, Dermatopathology, 2007 - 2008
- University of Arizona College of Medicine-TucsonResidency, Pathology-Anatomic and Clinical, 2003 - 2007
- University of Arizona College of MedicineClass of 2003
Certifications & Licensure
- AZ State Medical License 2006 - 2025
- CT State Medical License 2009 - 2010
- NY State Medical License 2008 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 26 citationsImmunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of...Katerina Dvorak, Amanda Higgins, John Palting, Michael Cohen, Patrick Brunhoeber
Pathology Oncology Research. 2019-01-01 - 24 citationsPrognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studiesUlrich-Peter Rohr, Pia Herrmann, Katharina Ilm, Hai Zhang, Sabine Lohmann
Annals of Oncology. 2017-08-01 - 24 citationsGirdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair Proficient Stage II Colon CancerPradipta Ghosh, Jeanne Tie, Andrea Muranyi, Shalini Singh, Patrick Brunhoeber
Clinical Cancer Research. 2016-03-30